Suggested treatment of serious complications to COVID-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme

J Thromb Haemost. 2021 Sep;19(9):2363-2364. doi: 10.1111/jth.15433. Epub 2021 Jul 9.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19 Vaccines*
  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Streptococcus pyogenes
  • Vaccination / adverse effects

Substances

  • COVID-19 Vaccines